Clinical Relevance of New World Health Organization Classification System for Pituitary Adenomas: A Validation Study With 2-Year Experience.

Hong, Seung Woo; Kim, Se Hoon; Lim, Seung Hoon; Lee, Eun Jig; Kim, Sun Ho; Ku, Cheol Ryong; Kim, Eui Hyun

Hong, Seung Woo; Kim, Se Hoon; Lim, Seung Hoon; Lee, Eun Jig; Kim, Sun Ho; Ku, Cheol Ryong; Kim, Eui Hyun.

Affiliation

Hong SW; Department of Neurosurgery, Yonsei University College of Medicine, Seoul, South Korea.
Kim SH; Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea.
Lim SH; Pituitary Tumor Center, Severance Hospital, Seoul, South Korea.
Lee EJ; Department of Neurosurgery, Yonsei University College of Medicine, Seoul, South Korea.
Kim SH; Pituitary Tumor Center, Severance Hospital, Seoul, South Korea.
Ku CR; Yonsei Endocrine Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
Kim EH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.

Front Oncol ; 11: 739290, 2021.

Article de En | MEDLINE | ID: mdl-34589436

Mots clés

WHO classification; immunohistochemistry; pituitary adenoma; pituitary hormone; transcription factor

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Front Oncol Année: 2021 Type de document: Article Pays d'affiliation: Corée du Sud

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google